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Delirium is associated with prolonged intensive care unit
(ICU) stay: its early recognition, treatment and prevention
are becoming increasingly important. Scales and evalua-
tion tools for delirium are becoming more diffuse, but a
universal tool has not been deﬁned yet, and probably
delirium underrating still permeates the ICU environment.
Spronk [1] investigated, during daily care, intensivists’
and ICU nurses’ skills in identifying the presence of
delirium in ICU patients. In a 3-month period, all patients
in the ICU for more than 48 h were screened daily for
delirium both by attending intensivists and nurses. The
Confusion Assessment Method for the ICU (CAM-ICU)
was used as a screening instrument for delirium. During
the study period, 46 patients (30 male, 16 female; median
age 73 years) with an ICU stay of 6 days (range 4–11)
were evaluated. CAM-ICU scores were obtained during
425 patient days. Considering the CAM-ICU as the ref-
erence standard, delirium occurred in 50% of the patients
with a duration of 3 days (range 1–9). Days with delirium
were poorly recognized by doctors (sensitivity 28.0%;
speciﬁcity 100%) and ICU nurses (sensitivity 34.8%;
speciﬁcity 98.3%). Recognition did not differ between
hypoactive or active status of the patients involved.
Delirium is severely underrecognized in the ICU in daily
care. These data indicated that more attention should be
paid to the implementation of a validated delirium-
screening instrument during daily ICU care.
The pathophysiology of delirium remains elusive.
Neurotransmitters and their precursor large neutral
amino acids (LNAAs) may play a role. Pandharipande
[2], exploring this relationship, evaluated if plasma
tryptophan (Trp), phenylalanine (Phe) and tyrosine (Tyr)
levels are independent risk factors for delirium in criti-
cally ill patients. This pilot study investigated whether
alterations of these amino acids were associated with a
higher risk of transitioning to delirium in critically ill
patients. Plasma LNAA concentrations were determined
on days 1 and 3 in mechanically ventilated (MV)
patients from the MENDS trial, a randomized controlled
(RCT) trial comparing an alpha2 agonist versus a
gamma aminobutyric acid (GABA) agonist to determine
delirium rates, efﬁcacy of sedation, analgesia and cog-
nitive status after ICU discharge. Three independent
variables were calculated by dividing Trp, Phe and Tyr
plasma concentrations by the sum of all other LNAA
concentrations. Delirium was assessed daily using the
CAM-ICU assessment method. The 97 patients included
in the analysis had a high severity of illness. After
adjusting for confounders, only high or very low tryp-
tophan/LNAA ratios (P = 0.0003) and tyrosine/LNAA
ratios (P = 0.02) were associated with increased risk of
transitioning to delirium. Older age, higher APACHE II
scores and increasing fontanel exposure were also
associated with higher probabilities of transitioning to
delirium.
The months following the ICU discharge can be
stressful for patients and family. One of the real problems
the ICU survivors face in daily life is the distance
between his/her psychological distress and the relatives’
expectations. A cross-sectional study of 255 patients and
298 relatives tried to clarify this important aspect [3]. A
questionnaire for post-ICU patients, tested 4–6 weeks
after ICU discharge, included hospital anxiety and
depression scale (HADS), impact of event scale (IES), life
orientation test, ICU memory tool and memory of ICU,
technical procedures, pain, lack of control and inability to
express needs. Relatives were assessed for their expec-
tations of the patients’ memories and psychological
distress. Twenty-ﬁve percent of the patients reported
severe posttraumatic stress symptoms, IES total C35. The
levels of anxiety and depression were signiﬁcantly higher
than in the general population; mean anxiety was 5.6
versus 4.2 (P\0.001), and mean depression was 4.8
versus 3.5 (P\0.001). Relatives expected more psy-
chological distress, and the relatives thought the patient
was less able to express needs than the patients reported
(P\0.001). Older age, unemployment, respirator treat-
ment, pessimism, memory of pain, lack of control and
inability to express needs were independent predictors of
posttraumatic stress symptoms (P\0.01).
Neuro-psychological syndromes often observed in
critically ill patients may be induced by the initial injury,
but also by the intensive care treatment itself. Two
interesting reviews dealt with this crucial ﬁeld: Figueroa-
Ramos et al. [4] investigated mechanisms and manifes-
tations of sleep and delirium in ICU patients. The speciﬁc
clinical features of sleep disturbances (fragmentation,
increase in light sleep, etc.) are presented, as well as the
most common subtypes of delirium, i.e., the hypoactive
and mixed-type delirium. The physiological background
is demonstrated to provide a better understanding of the
mechanisms and factors that contribute to sleep depriva-
tion and delirium, guiding the development of new
methods and models for prevention and treatment of these
problems. Davydow et al. [5] presented a systematic
review on depression in general ICU survivors. Fourteen
studies from the literature were eligible, and the median
point prevalence of ‘‘clinically signiﬁcant’’ depressive
symptoms was 28%.
Neither the severity of the disease nor sex nor age was
a consistent risk factor, whereas early post-ICU depres-
sive symptoms were a strong predictor for subsequent
depressive syndromes. These were associated with a
substantially lower quality of life. A multidisciplinary
approach involving intensivists, primary care physicians
and psychiatrists could ensure prompt, comprehensive
evaluation and treatment, reducing morbidity and
improving ICU survivors’ quality of life.
413Head trauma: transfusion and ICP treatment
Bleeding and hypotension are two targets in early head
trauma management, mainly when associated with poly-
trauma. Transfusion practices have been revisited more
than once in the last decades in trauma victims. The
optimal hemoglobin concentration in the early phase is
still a matter of debate. The fact that many actors play a
role in the early treatment of traumatic brain injury, i.e.,
surgeons, intensivists, anesthesiologists and neurosur-
geons, increases the confusion level. Their attitudes
toward transfusion practices for acute traumatic brain
injury have been explored using a survey in US trauma
centers [6]. The aim of the research was to determine
whether physician specialty inﬂuences the transfusion
threshold in patients with acute severe traumatic brain
injury. A scenario-based, multiple-choice instrument
administered was mailed to chiefs of trauma surgery,
chairs of neurosurgery, and surgical and neurosurgical
ICU directors at all 187 US level I centers. The hemo-
globin value used as a transfusion threshold for patients
with severe acute TBI in several scenarios as well as
opinions regarding the rationale for transfusion has been
evaluated. The response rate was 58% (312/534). Mean
time in practice was 17 ± 8 years, and 65% were board
certiﬁed in critical care. Neurosurgeons (NS) used a
greater mean hemoglobin threshold for transfusion of TBI
patients than trauma surgeons (TS) and non-surgeon in-
tensivists (CC) whether the intracranial pressure was
normal (8.3 ± 1.2, 7.5 ± 1.0 and 7.5 ± 0.8 g/dl; NS, TS
and CC, respectively, P\0.001) or elevated (8.9 ± 1.1,
8.0 ± 1.1 and 8.4 ± 1.1 g/dl; NS, TS and CC, respec-
tively, P\0.001). All three groups commonly believed
that secondary ischemic injury is an important problem
following TBI, but fewer neurosurgeons believed that
transfusions have important immunodulatory effects (25,
91 and 83%, P\0.001). NS prefer more liberal trans-
fusion of TBI patients than TS and CC, suggesting that
actual practice may depend largely on which specialist is
primarily managing care. The observed clinical equipoise
would justify a randomized trial of liberal versus
restrictive transfusion strategies in patients with TBI.
During the ICU stay, intracranial pressure patho-
physiology and its treatment become an important part of
the understanding and care of the TBI patients.
Lavinio [7] explored the relationship between the
intracranial pressure-volume index (PVI) and cerebral
autoregulation. The PVI, described originally by Mar-
marou, can be used to assess the cerebrospinal ﬂuid
dynamics and intracranial elastance in critically ill brain-
injured patients. The dependency of PVI on the state of
cerebral autoregulation within the physiologic range of
cerebral perfusion pressure (CPP) can be described by
mathematical models that account for changes in cerebral
blood volume during PVI testing. This relationship has
never been veriﬁed clinically using direct PVI measure-
ment and independent cerebral autoregulation assessment.
PVI and cerebral autoregulation were prospectively
assessed in a cohort of 19 comatose patients admitted to
an academic ICU. PVI was measured injecting a ﬁxed
volume of 2 ml of 0.9% sodium chloride solution into the
cerebral ventricles through an intraventricular catheter.
Cerebral autoregulation was assessed using transcranial
Doppler transient hyperemic response (THR) test. Fifty-
nine PVI assessments and 59 THR tests were performed.
Mean PVI was 20.0 (SD 10.2) ml in sessions when
autoregulation was intact (THR test C1.1) and 31.6 (8.8)
ml in sessions with defective autoregulation (THR
test\1.1) (DeltaPVI = 11.7 ml, 95% CI = 4.7–19.3 ml;
P = 0.002). Intracranial pressure, CPP and brain CT
ﬁndings were not signiﬁcantly different between the
measurements with intact and disturbed autoregulation.
Cerebral autoregulation status can affect PVI estimation
despite a normal CPP. PVI measurement may overesti-
mate the tolerance of the intracranial system to volume
loads in patients with disturbed cerebral autoregulation.
Intracranial hypertension after TBI is still a major
cause of mortality and morbidity in the ICU. Recent
randomized, controlled trials have failed to demonstrate
any beneﬁcial outcome from therapeutic treatments such
as corticosteroids, hypothermia and hypertonic saline.
Ichai [8] investigated the effect of a new hyperosmolar
solution based on sodium lactate versus mannitol in
controlling raised ICP. In a prospective, open, random-
ized study in an adult ICU, 34 patients with isolated
severe TBI and intracranial hypertension were allocated
to receive equally hyperosmolar and isovolumic therapy
(mannitol or sodium lactate). Rescue therapy by crossover
to the alternative treatment was indicated when ICP could
not be controlled. Compared to mannitol, the effect of the
lactate solution on ICP was signiﬁcantly more pro-
nounced (7 vs. 4 mmHg, P = 0.016), more prolonged
(4th-h ICP decrease: -5.9 ± 1 vs. -3.2 ± 0.9 mmHg,
P = 0.009) and more frequently successful (90.4 vs.
70.4%, P = 0.053). Therefore, acute infusion of a sodium
lactate-based hyperosmolar solution is effective in treat-
ing intracranial hypertension following TBI. This effect is
signiﬁcantly more pronounced than that of an equivalent
osmotic load of mannitol. Additionally, in this speciﬁc
group of patients, long-term outcome was better in terms
of GOS in those receiving it as compared to those
receiving mannitol. Larger trials are warranted to conﬁrm
these early ﬁndings.
As a second-tier option for controlling ICP, hypo-
thermia is still a ‘‘hot’’ topic. A trial for answering the
question of the real utility of hypothermia in reducing ICP
and ameliorating outcomes, Eurotherm3235, is going
to start soon (http://www.eurotherm3235trial.eu). The
debate between using invasive and non-invasive methods
for inducing hypothermia is still open. In a prospective,
414international, multicenter clinical trial conducted in four
university hospitals, Sahuquillo [9] evaluated the feasi-
bility, safety and effectiveness of a new method of
intravascular temperature management for inducing
moderate hypothermia (MHT). In a 2-year period, 24
patients with severe head injury and refractory high ICP
were treated with MHT (32.5C) by intravascular meth-
ods. Seventeen were males and seven females, with a
median age of 25 years (range 15–60). The median
Glasgow Coma Scale upon admission was 7 (range 3–13),
and the median Injury Severity Score was 22 (range 13–
43). A total of 75% of patients presented a diffuse lesion
in the pre-enrollment computed tomography. Median time
from injury until reaching refractory high ICP was 71.5 h
after injury (minimum 14 h, maximum 251 h). Twelve
patients (50%) reached this situation within the ﬁrst 72 h
after injury. MHT was attained in a median time of 3 h.
Pre-enrollment median ICP was 23.8 mmHg and was
reduced to 16.8 mmHg upon reaching target temperature.
At 6 months after injury, nine patients had died (37.5%),
six were severely disabled (25%), two moderately dis-
abled (8.3%) and seven had a good recovery (29.2%). Of
the nine patients who died, four had a rebound of ICP
during rewarming, one death was attributed to accidental
potassium overload, two to septic shock, one to cardiac
arrest of unknown origin and the ninth to a pulmonary
embolism. Intravascular methods to induce MHT com-
bined with precooling with cold saline at 4C appear to be
feasible and effective in reducing ICP in patients with
high ICP refractory to ﬁrst-line therapeutic measures.
ICU-acquired weakness and heat stroke sequelae
Hough et al. [10] investigated the incidence and outcomes
of ICU-acquired neuromyopathy and the role of methyl-
prednisolone in survivors of persistent acute lung injury.
They performed a secondary analysis on 128 patients who
survived 60 days or hospital discharge from the acute
respiratory distress syndrome (ARDS) Network RCT
study of methylprednisolone versus placebo for persistent
ARDS. Forty-three (34%) of these patients had evidence
of ICU-acquired neuromyopathy, which was associated
with prolonged mechanical ventilation and delayed return
to home after critical illness. Treatment with methyl-
prednisolone was not signiﬁcantly associated with an
increase in risk of neuromyopathy (OR 1.5; 95% CI 0.7–
3.2). ICU-acquired neuromyopathy was common among
survivors of persistent ARDS and was associated with
poorer clinical outcomes. Limitations of this study pre-
clude deﬁnitive conclusions about the causal relationship
between corticosteroids and ICU-acquired neuromuscular
dysfunction, but the association appears less strong than
before.
As stressed by Herridge in the accompanying editorial
[11], ICU-acquired weakness is common and conse-
quential, but we still know very little about its risk factors,
pathophysiology, natural history and potential treatment.
The very ﬁrst step should be to acknowledge that we have
not been looking hard enough for this problem and are
currently engaged in clinical practices that obscure our
ability to diagnose this problem.
The issue of ICU-acquired weakness was also
addressed by Kesler and co-workers [12] in a retrospec-
tive cohort study of MV patients with status asthmaticus.
The study compared asthmatic patients receiving
mechanical ventilation before (n = 96) and after
(n = 74) a clinical practice change in 1995 that markedly
restricted the use of paralytics. Even though the duration
of neuromuscular paralysis markedly declined, no sig-
niﬁcant difference in the incidence of weakness was
observed, highlighting that prolonged deep sedation
remains a risk factor for weakness.
During August 2003, France sustained an unusual heat
wave that lasted 9 days and caused epidemic classic
heatstroke. The course of early organ dysfunction in a
cohort of patients admitted to the ICU suffering classic
heatstroke has been described by Pease [13]. Clinical and
biological data of 22 patients were analyzed. Median
body temperature on admission was 41.1C. Respiratory,
circulatory, hematological, hepatic and renal function all
deteriorated within the ﬁrst 24 h of admission. ICU
mortality was 63.6%. Cooling time, serum lactate, serum
cardiac troponin I and creatinine were signiﬁcantly higher
in non-survivors. Early ICU mortality (within 7 days of
ICU stay) was due to multiple organ failure. Late ICU
mortality was due to neurological disability.
Hemodynamics
Intensive Care Medicine published several articles on
cardiovascular problems and failure in 2009.
The incidence of right ventricular failure (RVF) in
patients with ARDS and its impact on short-term outcome
was assessed byOsman etal. [14].This is a substudyofthe
previously published French Pulmonary Artery Catheter
(PAC) study. A total of 145 ARDS patients were included
in the substudy. The RVF was deﬁned by the concomitant
presence of: (1) a mean pulmonary artery pressure
(MPAP)[25 mmHg, (2) a central venous pressure (CVP)
higher than pulmonary artery occlusion pressure (PAOP)
and (3) a stroke volume index \30 ml/m
2. RVF was
present in 9.6% of patients. Mortality was 68% at day 90
with no difference between patients with or without RVF.
In multivariate analysis, PaO2/FiO2, mean arterial
pressure, arterial pH, SvO2, MPAP and presence of
CVP[PAOP, but not RVF, were independently
415associated with day-90 mortality. Although PaCO2 did not
seem to inﬂuence RVF in Osman’s paper, it seemed to
play an important role in the development in RVF in 11
ARDS patients in the paper by Mekontso Dessap et al.
[15]. RV function was assessed by transesophageal echo-
cardiography. Compared to low PEEP, PaO2/FiO2 ratio
and alveolar recruitment were increased with high PEEP.
Alveolar dead space remained unchanged. High-PEEP
strategies induced both higher PaCO2 levels [71 (60–94)
and 75 (53–84), vs. 52 (43–68) mmHg] and lower pH
values [7.17 (7.12–7.23) and 7.20 (7.16–7.25) vs. 7.30
(7.24–7.35)], as well as RV dilatation, LV deformation
and a signiﬁcant decrease incardiac index. The decrease in
stroke index tended to be negatively correlated to the
increase in alveolar recruitment with high PEEP.
Although a decrease in vascular tone after cardiac
surgery occurs frequently, its mechanism is unknown.
Based on data already published in sepsis, Jochberger and
co-worker [16] evaluated arginine vasopressin (AVP) and
copeptin plasma concentrations in patients with vasodi-
latory shock after cardiac surgery. Both biomarkers were
reduced in the vasodilatory shock group. Furthermore,
except during continuous veno-venous hemoﬁltration,
AVP and copeptin correlated signiﬁcantly with each
other.
Monge Garcia and co-workers [17] evaluated whether
arterial pressure response during a Valsalva maneuver
could predict ﬂuid responsiveness in spontaneously
breathing patients. A 10-s Valsalva maneuver was per-
formed before and after volume expansion. Arterial
response during the Valsalva maneuver seems to be a
feasible tool for predicting ﬂuid responsiveness in patients
without mechanical ventilatory support.
The research on cardiac arrest has received a new
impulse in the last few years. Carr and co-workers [18]
showed that mortality after in-hospital cardiac arrest had
decreased over 5 years in the US. This result is based on a
national sample of US hospitals identifying patients
resuscitated after cardiac arrest from 2000 to 2004. A total
of 109,739 patients were identiﬁed. Mortality after car-
diac arrest was lower at urban, teaching and large
hospitals.
Evaluation of hemodynamic alterations
Signiﬁcance of hypotension
Hypotension can be life threatening and is one of the most
frequent reasons for requesting ICU admission. Hypo-
tension is associated with a poor outcome, but the level of
hypotension associated with a poor outcome needs to be
determined. Two manuscripts addressed this issue from
different perspectives. Marchick et al. [19] evaluated the
impact of non-sustained (less than 60 min) hypotension in
a large database of 700 patients admitted with sepsis to
the emergency department (ED) of a single large urban
hospital in the USA. Among these, 150 developed non-
sustained hypotension. Mortality increased from 3.6% in
the general population to 10% in patients with non-sus-
tained hypotension. More severe hypotension was
associated with higher mortality, emphasizing that hypo-
tension, even when transient, should not be neglected in
patients with sepsis.
Dunser et al. [20] evaluated the impact of prolonged
hypotension in 274 patients with septic shock. They col-
lected mean and systolic arterial pressure values from the
data management system and computed the hourly time
integral for different threshold values. They observed a
curvilinear association between time spent with hypo-
tension and poor outcome. However, it was quite
surprising to notice that even time spent below the highest
mean arterial pressure tested, 75 mmHg, was signiﬁcantly
associated with a poor outcome. These results suggest that
not only the severity of hypotension, but also time spent
even with moderate hypotension is associated with a poor
outcome.
How to predict the response to ﬂuids
Fluids are a key component of the resuscitation of criti-
cally ill patients, but excessive ﬂuid administration should
also be avoided. Accordingly, techniques to predict the
response to ﬂuids are crucial. Respiratory induced pulse
pressure variations (PPV) have been shown to predict
response to ﬂuids. Unfortunately, PPV is sensitive to tidal
volume (TV) [21], as a TV higher than 8 ml/kg is
required. The main reason is that the respiratory changes
in pleural/pericardial pressures are low when TV is low.
Vallee et al. [22] hypothesized that correcting PPV for
driving pressure, as evaluated by plateau minus PEEP,
could be better predictive of ﬂuid responsiveness than
PPV alone, even in patients with low TV. In opposition to
their expectations, correction of PPV by driving pressure
failed to improve the predictive value for ﬂuid respon-
siveness in patients with low TV, whereas it effectively
did so in patients with high TV. As highlighted in the
accompanying editorial by Lefrant and De Backer [23],
transmission of alveolar pressure to pleural and pericar-
dial space is altered in ARDS patients who require
ventilation with low TV. Accordingly, respiratory driving
pressure fails to reﬂect respiratory changes in pleural and
pericardial pressures that really drive the changes in left
and right ventricular preload.
Passive leg raising (PLR) can also help to predict the
response to ﬂuids [24]. This maneuver evaluates rapid
changes in stroke volume in response to an acute change
in posture. Jabot et al. [25] evaluated whether this
maneuver should include PLR only, without movement of
the torso, or whether it should also include a rapid shift in
416torso position from 30 to 0, in addition to raising the
legs. The authors decomposed the movement and reported
that PLR and torso inclination were responsible for sim-
ilar mobilization of blood from the peripheral to the
central compartment, as evidenced by a similar increase
in CO with the two movements. They concluded that PLR
should include inclination of the torso from 30 to 0.
Devices and techniques
Different technologies can be used to estimate CO. One of
the major issues when introducing a new technology is to
evaluate its reliability. As no gold standard exists, the new
device is often compared with existing devices/tech-
niques, and often thermodilution is used as the
comparator. Often these comparisons are made at prede-
ﬁned times, but one of the major issues is to evaluate
whether the technique is able to adequately track changes.
No clear methodology exists for this purpose. In a special
article, Squara et al. [26] discussed the various aspects
needed to evaluate new devices. In addition to accuracy
and precision (static estimates), response time and accu-
racy of estimation of amplitude of the response (dynamic
estimates) should also be provided when introducing new
techniques. For this purpose, they proposed to evaluate
the changes in CO occurring after a known intervention
and to evaluate response time and amplitude with new
and reference techniques. The deﬁnition of clinical
acceptability of these estimates will need to be deﬁned.
CO can be measured by various techniques analyzing
the morphology of the arterial curve. According to the
algorithm, it may be necessary to calibrate the system
with an independent measurement of CO. With the LiD-
CO device, lithium dilution is used to calibrate the pulse
power analysis of the arterial trace, allowing for accurate
continuous measurements of CO. However, this process
carries an inherent risk of error, and great care should be
taken when performing calibrations. Cecconi et al. [27]
evaluated the reproducibility of lithium dilution mea-
surements, performing four subsequent lithium dilution
measurements. They observed that the coefﬁcient of
variation of a single measurement was 8%, which implies
that the technique is able to detect signiﬁcant changes in
CO of at least 24%. Averaging two and three lithium
boluses decreased the coefﬁcient of variation to 6 and 5%
and the least signiﬁcant detectable difference in CO to 17
and 14%, respectively. It did not further improve when
additional lithium injections were performed. The authors
concluded that at least three bolus injections should be
performed to calibrate the LiDCO device.
Dancona et al. [28] tested a continuous cardiac output
(CO) recording system that operates on the thermal con-
servation principle, and they compared it with the
reference standard transit time ﬂow measurement. There
was a signiﬁcant underestimation of CO with the con-
tinuously recording system, but it may be useful to detect
trends over time.
Another important aspect is evaluating whether CO is
adequate. Mixed-venous and central venous (ScvO2)O 2
saturations are often used for this purpose. In addition,
ScvO2 is used to guide the early resuscitation in septic
shock [29]. However, these require insertion of a central
venous line, which is not always easily available in the
early phases of resuscitation. In 40 consecutive patients
with severe sepsis, Mesquida et al. [30] evaluated
whether the non-invasive measurement of tissue O2
saturation (StO2) of the thenar eminence with near
infrared spectroscopy (NIRS) could predict ScvO2 val-
ues. Even though a StO2 value below 75% was
associated with aScvO2 lower than 70% with a high
speciﬁcity (0.93), many patients with a StO2 value above
75% could still have a low ScvO2 (sensitivity 0.44).
Accordingly, the positive predictive value of StO2 was
high (0.92), whereas the negative predictive value was
low (0.52). Accordingly, when abnormal, this test can
easily detect low ScvO2, but a normal StO2 value should
not be considered reassuring.
A new look at the microcirculation
Several studies have reported the implication of the
microcirculation in sepsis [31], cardiac failure [32] and
hemorrhagic shock [33], but its implication in other
disease states remains to be demonstrated. Jhanji et al.
[34] investigated the sublingual microcirculation in 25
patients admitted to the ICU after major abdominal sur-
gery. Microcirculatory perfusion was close to normal on
ICU admission, but slightly deteriorated in the following
8 h in patients developing complications, whereas there
was full normalization in patients who did not develop
complications. Global hemodynamic measurements did
not differ between patients developing complications and
patients with an uneventful postoperative course. Even
though obtained in a small group of patients, these pre-
liminary data suggest that microcirculatory alteration
may play a key role in the development of postoperative
complications.
When looking at the microcirculation, one is some-
times limited by the scoring systems. In most articles,
semi-quantitative assessment is performed, as automated
analysis still requires multiple human interventions. A
limitation for future wide application at bedside of these
techniques of direct visualization of the microcirculation
is that theses semi-quantitative scoring systems need to
be performed off-line and are rather time consuming.
Ideally, eyeball evaluation of key microcirculatory fea-
tures at bedside should be obtained by analogy with
eyeballing of the ejection fraction at bedside, which has
been proven to be as reliable as more cumbersome
417off-line determinations [35]. Arnold et al. [36] evaluated
whether rapid eyeball evaluation of the microcirculation
(in a point of care fashion) could reliably estimate the
microculation, as compared to off-line analysis. They
obtained 205 paired measurements in 18 subjects. There
was no bias between measurements, and agreement
between point of care and off-line analysis was excellent
(0.19, representing a percentage error smaller than 10%).
The authors concluded that point of care evaluation of
the microcirculation can reliably assess the sublingual
microcirculation.
We are still looking for interventions that could spe-
ciﬁcally (or at least predominantly) improve the
microcirculation. Vasodilatory agents seem promising,
but these have not been widely tested. Den Uil et al. [32]
evaluated the effects of nitroglycerine on the sublingual
microcirculation in 17 patients with heart failure (n = 8)
or cardiogenic shock (n = 9). More importantly, they
evaluated the dose response to this agent, using incre-
mental doses up to 133 lg/min. They observed that all
patients improved their microcirculation with nitroglyc-
erin, but that the dose required to achieve this effect
varied widely among patients. More importantly, even
though nitroglycerin was also associated with systemic
effects, the improvement in microvascular perfusion
occurred at lower doses than the systemic effects, sug-
gesting that this agent could be used to speciﬁcally
improve the microcirculation at doses not resulting in
signiﬁcant hypotension.
How to treat hemodynamic alterations
The quest for the ideal ﬂuid for hemodynamic resuscita-
tion is still ongoing. In particular, there is still a huge
discussion going on about the potential beneﬁts and risks
of colloid solutions, and in particular of starches. This
issue was raised in the Journal in a pro-con debate between
Hartog and Reinhart [37] defending the contra side and
Boldt [38] defending the pro side. Hartog and Reinhart
raised the issue of storage of hydroxyethylstarch (HES)
molecules in the reticulo-endothelial system and skin,
which may lead to pruritus. In addition, they highlighted
that nephrotoxicity has been suggested to occur in several
randomized trials and that the volume-expanding capaci-
ties of these solutions may be lower than the expected 4–1.
They concluded that in the absence of a clearly demon-
strated beneﬁcial effect and in the presence of potential
side effects, one should refrain from using these solutions.
Boldt supported the opposite point of view. This author
highlighted that the side effects, especially nephrotoxicity,
have been observed using only hyperoncotic HES of large
molecular weight. Based on data from small interventional
trials, he suggested that new-generation HES may not be
associated with nephrotoxicity and that there is no reason
to ban these new solutions.
In a before and after trial, Schabinski et al. [39]
compared the effects of a predominantly HES- and
predominently non-HES-based ﬂuid therapy on renal
function in surgical patients. In this single center, the
authors compared the cohort of patients admitted between
January and June 2005 receiving a ﬂuid therapy mostly
based on HES and a cohort of patients admitted from
January to June 2006 receiving mostly gelatins as part of
their ﬂuid resuscitation. The two cohorts were relatively
well balanced both in numbers (1,383 vs. 1,528) and main
diagnoses (even though there were more cardiac surgery
and neurosurgery and fewer digestive tract surgery
patients in the gelatin group). The incidence of renal
failure did not differ between the two groups (5.8 and
5.6%). By multivariate analysis, the authors identiﬁed that
a cumulative dose of either HES or gelatin of at least
33 ml/kg body weight was associated with an increased
incidence of renal failure and death, but again without a
difference between the two groups.
Finally, Boldt et al. [40] evaluated the inﬂuence of the
ionic content of ﬂuid solutions. These authors compared a
HES solution dissolved in 9% saline and another solution
of the same HES dissolved in a balanced solution. Saline
solutions present the disadvantage of carrying an excess
of chloride anions compared to sodium, which can gen-
erate hyperchloremic acidosis. Balanced solutions contain
equivalent amounts of anions and cations,but both sodium
and chloride are present in physiologic ranges, electrical
neutrality being provided by additional lactate or acetate.
The authors randomized 50 elderly patients submitted to
cardiac surgery and evaluated the impact of these two
solutions on inﬂammatory response. They reported that
patients treated with HES in balanced solution, compared
to HES in saline solution, had lower levels of interleukin
6 and 10 and soluble intracellular adhesion molecule-1
(ICAM-1), representing a blunted inﬂammation and
endothelial activation after surgery. In addition, markers
of kidney injury (NGAL and alpha-GST) increased less in
the balanced group, whereas creatinine was not affected
in either group, suggesting a better preserved kidney
integrity.
Experimental studies
Sepsis
Permissive hypercapnia is a frequent practice in patients
ventilated for an ARDS. However, effects of respiratory
acidosis on cell functions are not well known. Morisaki
et al. [41] induced hypercapnic acidosis by ventilating
rabbits with an atmosphere enriched with CO2. Hyper-
capnia was associated with a reduction of gastric
intramucosal pH and a reduced intestinal vascular
permeability after endotoxin infusion. Interestingly,
418hypercapnic acidosis did not inﬂuence endotoxin-
induced gut neutrophil recruitment, suggesting that the
observed protective effects might be independent of
neutrophils. Using a similar approach, Gnaegi et al. [42]
demonstrated that moderate hypercapnia prevented the
deterioration of gut tissue energetics in endotoxemic
rats. Endotoxic rats had a decrease in ATP and an
increase in lactate concentrations in the gut, changes
that were largely prevented by hypercapnia. Interest-
ingly, this preventive effect of hypercapnia was not
observed on liver energetic parameters. Oppositely,
hypocapnia worsened shock induced by endotoxin, as
well as bioenergenetic parameters measured in the cir-
culation. In a gut ischemia/reperfusion model in rats,
Di Paola et al. [43] demonstrated that glycyrrhizin, a
component of licorice with anti-oxidant effects, pro-
tected against gut injury. Glycyrrhizin signiﬁcantly
decreased gut inﬂammation and neutrophil recruitment
induced by a clamping and release of the splanchnic
arteries, most probably by decreasing oxidative stress in
this model.
Until now, the relevance of sepsis and endotoxemic
models in mice has suffered from the fact that the ani-
mals were not resuscitated with ﬂuids. Zanotti-
Cavazzoni et al. [44] showed that, similarly to larger
animals, the cardiovascular performance was profoundly
inﬂuenced by ﬂuid resuscitation in mice submitted to
cecal ligation and puncture (CLP) and treated with
antibiotics. Using echocardiography, these authors
demonstrated that ﬂuid infusion increased both left
ventricular stroke volume and CO and prevented mor-
tality in a dose-dependent manner. These results stress
the importance of introducing ﬂuid resuscitation in
murine models to better mimic human septic shock and
conﬁrm the beneﬁcial effects of early ﬂuid loading in
this condition. Baumgart et al. [45] investigated the
possible role of Cu/Zn superoxide dismutase (SOD-1) in
the cardiovascular response of mice submitted to CLP
and resuscitated with ﬂuids. The overexpression of SOD-
1 in genetically modiﬁed mice did not ameliorate sepsis-
related impairment of myocardial norepinephrine
responsiveness, possibly because of the lack of increase
in tissue catalase and mitochondrial SOD activity
observed in this model. Using a rat endotoxic shock
model described in Intensive Care Medicine in 2008
[46], Hagiwara et al. [47] investigated the effect of
losartan, an antagonist of the type-1 angiotensin II
receptor, on lung injury. Circulating pro-inﬂammatory
cytokines and the alarmin HMGB-1 [48, 49] were
markedly reduced in endotoxemic rats receiving losar-
tan. Losartan also inhibited the LPS-mediated decrease
in angiotensin-converting enzyme 2 activity and the
labeling of this enzyme in the lung. In addition, losartan
reduced pro-inﬂammatory activity induced by endotoxin
in murine macrophages, suggesting a protective and
anti-inﬂammatory role for antagonists of the type-1
angiotensin II receptor. Interest in vasopressin has
increased recently with the VASST study of the treat-
ment of septic shock in association with norepinephrine.
Rehberg et al. [50] compared vasopressin and terlipres-
sin in a fecal peritonitis model causing fulminant septic
shock in sheep resuscitated with ﬂuids and norepineph-
rine. Compared to vasopressin, terlipressin reduced the
positive net ﬂuid balance, increased central venous
oxygen saturation and prolonged survival, but increased
liver enzymes, a ﬁnding consistent with splanchnic
ischemia. Clearly terlipressin was not equivalent to
vasopressin and requires further testing before being
proposed as a ﬁrst-line drug in human septic shock. In
another study, Wolff et al. [51] tested the modulation of
the brain gene expression by iNOS inhibitors versus
norepinephrine in endotoxin-treated rats. Using a
microarray technique followed by a validation using
PCR, these authors found that endotoxin induced a
marked modiﬁcation in the brain gene expression of
chemokines and endothelial cell-speciﬁc proteins,
mainly within the hypoccampus. Whereas norepineph-
rine treatment somewhat increased chemokine
expression in the brain, the iNOS inhibitor had no effect.
These results show that LPS-induced shock has a pro-
inﬂammatory effect on the brain, principally on the
hypoccampus, an effect that is further upregulated by the
co-administration of norepinephrine. A large debate
exists on the possible beneﬁcial effects of treating septic
shock patients with high-volume hemoﬁltration. Sykora
et al. [52] tested a high versus low volume hemoﬁltra-
tion protocol in a hyperdynamic septic shock porcine
peritonitis model. Hemoﬁltration was associated with
less requirement of norepinephrine. However, neither
low- nor high-volume hyperﬁtration induced a signiﬁ-
cant change in microvascular, metabolic, endothelial and
lung functions compared with a non-ﬁltrated control
group of sheep in this model. Given the antiinﬂamma-
tory and antiapoptotic properties of levosimendan,
Scheiermann and colleagues [53] reported the effects of
intravenous and nebulized levosimendan administration
3 h after the induction of CLP-induced sepsis in rats.
They demonstrated a higher mean arterial pressure,
arterial BE and pH; an increase in survival rate; a
reduction in IL 6 and IL1b levels in plasma; and a
reduction in cleaved caspase-3 concentration in the
spleen in both treatment groups as compared to the
control group. However, the mechanisms by which
the administration of levosimendan improve cell viabil-
ity and thus survival are still not understood. There are
reports showing signiﬁcant improvement of the cardiac
index in sepsis or even refractory septic shock as a result
of improving cardiac contractility by levosimendan
rather than the anti-apoptotic effects. This concept is
open for further studies.
Leukocyte reprogramming with a dominant immu-
nosuppressive phenotype is a hallmark of sepsis and is
419believed to play a signiﬁcant role in the propensity of
septic patients to acquire nosocomial infections. In a
series of elegant experiments, Leendertse et al. [54]
tested the hypothesis that a sublethal peritonitis (CLP)
would inﬂuence the capacity of mice to clear a second
bacterial infection caused by vancomycin-resistant
enterococci (VREs). VREs did not induce the local
inﬂammatory reaction required for their clearance when
injected intraperitoneally in mice previously rendered
septic by CLP. VRE bacterial loads were found increased
in the peritoneum and in distant organs when compared
with mice with a sham operation. This study highlights
the critical importance of bacteria-induced inﬂammation
as a key mechanism required for the clearance of bac-
teria. When the inﬂammatory reaction is small or absent
due to a previous sepsis injury, the immune system is
paralyzed and inefﬁcient in ﬁghting against a secondary
bacterial infection, a situation that is reminiscent of that
of human septic shock patients at high risk of developing
(severe) nosocomial infections from commensal bacteria.
Mediators responsible for the immune anergy observed
during septic shock are not very well known. Although
circulating anti-inﬂammatory cytokines such as IL-10
have been implicated in this phenomenon, it has also
recently become apparent that immune deactivating cells
such as CD4(?)CD25(?)Foxp3(?) regulatory T cells
(Tregs) are increased during sepsis and may play a role
in the so-called sepsis-associated ‘‘immune paralysis.’’
Venet et al. [55] investigated whether Tregs participated
in lymphocyte anergy during septic shock. They showed
that the proliferation capacity of T cells was markedly
impaired by the presence of Tregs. An inverse correlation
was observed between the number of circulating Tregs
and the proliferation of target T cells. They elegantly
showed in septic mice that the ex vivo silencing of
Foxp3, a Treg protein essential for their ‘‘immunosup-
pressive’’ effects, restored the proliferative capacity of
T cells.
Nebulization of antibiotics is becoming a valuable
therapeutic option in the treatment of pneumonia in crit-
ically ill patients. Many of the technical aspects of drug
delivery to the lung by nebulization have been tested and
optimized in animals, showing much higher airway con-
centrations compared to an IV route [56]. Ferrari et al.
[57] compared treatment of ceftazidime delivered either
by nebulization or IVs in pigs inoculated into the lungs by
a strain of P.aeruginosa with a decreased sensitivity to
this antibiotic. They demonstrated that the IV route was
much less efﬁcient than the nebulization route in con-
trolling bacterial proliferation in all lung segments
cultured. These results suggest that nebulization is capa-
ble of depositing higher bactericidal concentrations of
antibiotics into the lung than the IV route, an effect that is
particularly valuable in patients infected with bacteria
with reduced sensitivity to antibiotics.
Mechanical ventilation and acute lung injury
Several studies compared different approaches to the lung
recruitment maneuver in animal models of acute lung
injury and provided our readers with interesting ﬁndings.
It is important to identify the most reliable readouts to set
adequate individual levels of open lung PEEP during
recruitment. In a sheep model of acute lung injury
induced by bilateral lung lavage, Caramez et al. [58]
compared parameters measured during a decremental
PEEP trial with those obtained from P-V curves following
recruitment maneuvers. The authors observed a similar
PEEP identiﬁed by the dynamic tidal respiratory com-
pliance, maximum PaO2, maximum PaO2 and PaCO2,
minimum shunt, the inﬂation limb of lower Pﬂex or
deﬂation limb upper Pﬂex from quasi-static P-V curves in
their study set following a recruitment maneuver. How-
ever, it is unknown whether the parameters of readouts
reported in Garamez’s study are sensitive enough to
detect the differences of lung recruitment. Interestingly,
Dellaca et al. [59] assessed lung recruitment by moni-
toring the amount of derecruited lung using the forced
oscillation technique in piglets. The investigators simul-
taneously measured the oscillatory compliance by using
the forced oscillation technique and the percentage of
non-aerated lung tissue by CT scan. Measurements were
conducted before and after several interventions including
mono- and bilateral atelectasis, and lung recruitment
maneuvers. They reported a linear correlation between the
two methods in measuring lung volume and suggested
that the forced oscillation technique may be a useful tool
for the non-invasive measurement of lung recruitment or
derecruitment in addition to the existing methods.
To achieve optimal open lung results, Steimback et al.
[60] evaluated the effects of frequency and inspiratory
plateau pressure during recruitment maneuvers in para-
quat-induced lung injury in rats. Two sigh frequencies at
10 or 180 sighs/h were applied in combination with a
plateau pressure of either 20 or 40 cmH2O, respectively.
The authors demonstrated that a higher sigh frequency led
to lung and kidney epithelial cell apoptosis associated
with increased gene expression of the extracellular matrix
protein type III procollagen. They further showed that a
combined strategy of high sigh frequency with a lower
plateau pressure may even worsen lung injury. A different
picture was seen by Pellicano et al. using high-frequency
oscillatory ventilation in combination with different
stepwise escalating pressures [61]. The researchers com-
pared four methods of lung volume recruitment during
high frequency oscillatory ventilation in an acute lung
injury model of neonatal piglets after repeated saline
lavage. The four methods included a stepwise increase in
pressure over 6 min to a peak mean airway pressure
12 cmH2O above basal pressure; a sustained dynamic
inﬂation for 20 s to the same peak pressure; a sustained
420dynamic inﬂation repeated six times for 1 s each; and
mean airway pressure set directly at basal pressure. The
investigators reported that all methods resulted in a
reduction in non-aerated lung, with the greatest redistri-
bution to normally aerated lung being with stepwise
recruitment. The studies are of interest with respect to
searching for optimal approaches to lung recruitment. It
would be good for our readers to know about the gas
volume distribution within an injured lung after lung
recruitment maneuvers, as overinﬂation in previously
well-aerated lung is designated to be minimal.
Acute lung injury is characterized by excessive
inﬂammatory responses. To further explore the mecha-
nisms by which inadequate mechanical ventilation
induces lung injury, Martı ´nez-Caro et al. [62] demon-
strated that increased formation of reactive oxygen and
nitrogen species is involved in ventilator-induced vascular
dysfunction in rats. The authors reported that the use of
TV at 35 ml/kg and zero PEEP resulted in hypotension,
systemic acidosis, hypoxemia and hyperlactatemia in
vivo, and impaired vasoconstriction in response to ace-
tylcholine and norepinephrine challenge in aortic rings.
Immunostaining for both superoxide and nitrotyrosine
was increased in aortic rings; thus, pre-treatment of the
vascular rings with tempol (an intracellular superoxide
scavenger) or MnTMPyP (a superoxide and peroxynitrite
scavenger) improved acetylcholine- or norepinephrine-
induced vasoconstriction. These data suggest a role of
intracellular reactive oxygen and nitrogen species in
ventilation-induced vascular dysfunction. In another
study, Bueltmann et al. [63] examined the effects of
inhaled milrinone, a phosphodiesterase 3 inhibitor, in
models of acute lung injury following infusion of oleic
acid in rats or intratracheal instillation of hydrochloric
acid in mice. They demonstrated that a single inhalation
of milrinone decreased myeloperoxidase activity and
neutrophil counts, reduced protein concentration and
TNF-a production in bronchoalveolar lavage, and atten-
uated lung injury. The lung protective effects of
aerosolized milrinone administration were further
enhanced when milrinone was repeatedly inhaled. They
two further support that there may be a place for phar-
macological intervention by targeting inﬂammatory
responses in reducing ventilator-induced lung injury.
Ischemia/reperfusion and sepsis associated distal
organ failure
Several studies investigated regional blood ﬂow and
oxygenation during ischemia and reperfusion injury,
which may help enhance our understanding of the path-
ophysiology of distal organ injury.
Dubin et al. [33] measured systemic hemodynamics as
well as microcirculatory changes at different vascular
beds during progressive hemorrhage in anesthetized and
MV sheep. The investigator reported that over a broad
range of CO and superior mesenteric artery blood ﬂow,
the changes in intestinal serosal and mucosal capillary
microvascular blood ﬂow, and red blood cell velocities
are more susceptible than the changes of mean arterial
blood pressure, arterial pH and base excess, and intra-
mucosal-arterial PCO2 in response to progressive
bleeding. They suggested that the microcirculatory
changes measured by the semi-quantitative ﬂow index
may help detect microcirculatory alternations at an early
stage prior to global hemodynamic deterioration. The
concept of measuring microcirculation at the organ sys-
tem is of importance. The regional blood ﬂow device is
yet to be tested in other experimental conditions, and the
feasibility of using the invasive technique is yet to be
investigated at bedside monitoring. This study by Dubin
et al. is in agreement with previous studies showing that
global hemodynamics may fail to reﬂect changes in
regional blood ﬂow at distal organs. In another interesting
study, Dyson et al. [64] compared the changes of global
oxygenation with that measured in liver, kidney, muscle
and bladder in response to a variety of inspired oxygen
concentrations during progressive hemorrhage in sponta-
neously breathing, anesthetized rats. The authors
observed that survival times following progressive hem-
orrhage were similar in animals breathing room air, 60 or
100% O2, but signiﬁcantly worse in rats breathing 15%
O2. However, a decreased blood pressure and aortic blood
ﬂow and an increased lactatemia were observed in the
hypoxemic and hyperoxemic groups compared to nor-
moxemic animals. It appears that high FiO2 or
hyperoxemia cannot compensate for the low CO and thus
tissue perfusion. This study indicates that hypoxemia and
hyperoxemia both altered organ perfusion during severe
and progressive hemorrhage. In an editorial, Dr. Douzinas
[65] stated that we should keep in mind that CO and
mixed venous oxygen tension are higher in isovolemic
anemia than hypovolemia or hypoxemia. Therefore, it
would be interesting to resuscitate the animals at different
levels of blood volume loss and, by varying FiO2 and
measuring oxidative parameters, to determine if the
management should mainly lie with O2 therapy or with
resuscitation efforts.
To further explore the relationship between systemic
perfusion and tissue oxygenation, Hare et al. [66] inves-
tigated the effects of oxygen afﬁnity for optimal tissue
oxygen delivery in extreme hemodilution status by
administration of a hemoglobin-hydroxyethyl starch
conjugate (HRC 101) in rats. They reported that hippo-
campal tissue oxygen tension was best maintained after
hemodilution with low but not high afﬁnity HRC 101 at
Hb 100 and 70 g/l after near complete blood volume
exchange in rats. This is an interesting study that tests
oxygen delivery with a hemoglobin-based oxygen carrier
that can be constructed to have high and low oxygen
afﬁnity. The rationale for this model was that it would be
421easier to compare otherwise identical Hb in the absence of
red blood cells in which the Hb would be the primary
contributor to oxygen delivery.
In a rat intestinal ischemia-reperfusion model, Liu and
colleagues [67] demonstrated that immediate but not
delayed postconditioning carries protective effects. The
underlying mechanisms may involve inhibiting oxidant
generation and reducing the release of proinﬂammatory
mediators, etc. There are two major ﬁndings, namely that
post-conditioning and pre-conditioning exert an appar-
ently synergystic effect in this model, and if
post-conditioning is deferred until several minutes of
reperfusion have elapsed, the apparent protective effect is
lost. Both of these observations may have important
clinical implications. The observations regarding timing
may explain the apparent failure of post-conditioning in
some series and has important implications for future trial
design.
It has been known for many years that cooling alters or
reduces the coagulation system, and clinical data show
that ‘‘NovoSeven’’ will not work in hypothermic patients.
Hypothermia also results in changes in the cell surface
lipid membrane, reduced platelet function and altered
platelet morphology observed during hypothermic bypass
surgery. Krouzecky et al. [68] elegantly demonstrated that
cooling of blood in the extracorporeal circuit of contin-
uous veno-venous hemoﬁltration enables preventing
in-circuit clotting without the need to use any other
anticoagulant. Dr. Davenport made comments that, as any
young transplant surgeon knows, clotting and bleeding
during any major transplant operation in heart, lung and
liver differ when operating on pigs, dogs and humans. So
it must be stressed that these results are from pig exper-
iments. Secondly, in humans extracorporeal clotting
during dialysis for example can occur independently of
activation of factor XII, which was measured in the study
by Krouzecky and colleagues. Also, as pointed out by
Bagshaw and Davenport [69], the study only applied
regional blood cooling of the extracorporeal circuit in
their experimental model for a short duration. Additional
investigations using a longer duration of CRRT with
regional blood cooling in their model are needed to
evaluate both efﬁcacy and effectiveness, but also impor-
tantly safety, speciﬁcally in terms of temperature-induced
hemolysis with repeated blood cooling and re-warming.
Pharmacology and sedation
Drug-drug interactions are a difﬁcult ﬁeld of intensive
care medicine because of the application of multiple
different classes of drugs and the large heterogeneity of
the patients. One aspect in this context is the involvement
of CYP450-mediated interactions, which is reason enough
to give priority to this issue for a Mini Series on Basic
Research-Related Topics in Intensive Care Medicine:
Mouly et al. [70] concentrated on the basic science in Part
1 of the Mini Series. The authors present the clinical
rationale for this important ﬁeld of research to introduce
the reader to the basics of the CYP450 system. Subfam-
ilies of this enzyme group are mentioned, as well as
inducers and inhibitors of the major CYP enzymes. In
vitro systems to assess drug metabolism and interactions
are shown to act as potentially useful tools during the
preclinical step of drug development. Finally, ‘‘computer-
assisted’’ prediction systems are presented as an inter-
esting view into the future. Spriet et al. [71] focus on the
clinical aspects including relevant CYP450-mediated
drug interactions in the ICU. Multiple drug therapies are
common for ICU patients, and the practicing intensivist
must remain aware of the major mechanisms for drug-
drug interactions. This manuscript covers a practical
overview of clinically relevant interactions. Frequently
used medications, such as benzodiazepines, immunosup-
pressive agents, opioids, certain anticonvulsants, the
azoles and macrolides, have the potential to interact with
the CYP450-mediated metabolism and may lead to tox-
icity or therapeutic failure. Especially this second part is
an extremely important tool for every intensivist!
Adverse drug reactions (ADR) are a noxious, unin-
tended and undesired effect of a drug that occurs at
doses used in humans for prophylaxis, diagnosis or
therapy. The incidence of serious and fatal ADR is high.
Schwake et al. [72] aimed (1) to determine the preva-
lence of ICU admissions resulting from an ADR and (2)
to compare affected patients with patients admitted to
the ICU for the treatment of deliberate self-poisoning
using medical drugs. A total of 1,554 patients admitted
on 1 January 2003 to 31 December 2003 in a 14-bed
medical ICU were prospectively studied. Ninety-nine
patients were admitted to the ICU with a diagnosis of
ADR (6.4% of all admissions); 269 admissions (17.3%)
were caused by deliberate self-poisoning. Patients
admitted for treatment of ADR had a signiﬁcantly higher
age, a longer treatment duration in the ICU, a higher
SAPS II score and a higher 6-month mortality than those
with deliberate self-poisoning. Most patients (71.7%)
suffering from ADR required advanced supportive care
in the ICU, whereas the majority of patients (90.7%)
with deliberate self-poisoning could be sufﬁciently
treated in the integrated intermediate care area. All
diagnostic and therapeutic procedures in the ICU except
mechanical ventilation were performed signiﬁcantly
more often in patients with ADR. It was concluded that
ADR is a frequent cause of admission to medical ICUs
resulting in a considerable use of ICU capacities and that
patients with ADR required longer and more intense
medical treatment in the ICU than those with deliberate
self-poisoning.
In an observational case series from Western Austra-
lia, Brown et al. [73] reported that early clotting factor
422replacement to treat snake venom-induced comsumption
coagulopathy resulted in earlier recovery.
It is especially appreciated when investigators have
the courage to present research on very rare, but some-
times important topics in intensive care medicine. One
example is the paper by Struck et al. [74], who reviewed
the current literature on severe cutaneous adverse reac-
tions that are not associated with burn injuries. They
presented life-threatening examples, such as cases of
Steven-Johnson syndrome and toxic epidermal necrolysis,
and concluded that these patients will substantially beneﬁt
from early interdisciplinary care and thorough consider-
ation of complications during transport and intensive care
treatment. The attending medical team should be aware of
possible underlying diseases and instigating substances,
and these patients should be treated in a manner similar to
severe burn patients.
Short-term analgosedation with intravenously admin-
istered short-acting drugs is associated with signiﬁcant
cost. Analgosedation by inhalative agents appears to be an
intriguing alternative, which was investigated in 17 ICU
patients requiring mechanical ventilation [75]. The fea-
sibility of sedation with sevoﬂurane using the anesthetic
conservative device (AnaConDa) for short-term sedation
was tested. The application was found to be safe, and
hemodynamic tolerance was good, but the induction and
termination waking times were longer than when using
remifentanil and propofol.
The hepatic metabolism of another commonly used
drug, midazolam, is altered during critical illness. Kirwan
et al. [76] used this property to explore the reliability of a
single measurement of midazolam concentration as an
indicator of hepatic drug metabolism. The ﬁndings of this
study indeed conﬁrmed a satisfactory correlation between
the single midazolam concentration and the area under the
curve of the plasma concentrations. The presence of acute
kidney injury was associated with increased midazolam
concentration.
In a pilot, phase III, double-blind multicenter study of
85 randomized medical and surgical patients, Ruokonen
et al. [77] compared dexmedetomidine (1.4 lg/kg/h) with
propofol/midazolam for long-term sedation. Target RASS
was reached in 64% of patients receiving dexmedetomi-
dine and in 63% of control patients. Similarly, the length
of ICU stay was similar. Dexmedetomidine was compa-
rable to propofol/midazolam in maintaining sedation
targets of RASS of 0 to -3. However, patients with a
RASS target of -4 or less reached the target in 42% of
the cases with dexmedetomidine and in 62% with pro-
pofol/midazolam (P = 0.006).
In a prospective study, Chanques et al. [78] validated
an adaptation of the Behavioral Pain Scale for use in non-
intubated delirious patients (BPS-NI). One physician and
the bedside nurse rated the level of pain during catheter
dressing change and turning in 30 consecutive adult
patients. Delirium was assessed by the CAM-ICU. Pain
scores were higher during painful procedures than at rest,
whereas no changes in pain scores were found during
non-nociceptive procedures. The BPS-NI showed good
internal consistency, good inter-rater reliability and good
responsiveness.
Tardy-Poncet et al. [79] reported danaparoid cross-
reactivity with heparin-induced thrombocytopenia anti-
bodies in 12 patients treated with lepirudin. They
concluded that the absence of any increase in platelet
count after 3–5 days of danaparoid therapy and/or the
occurrence of a new thrombotic event should lead to
suspicion of danaparoid cross-reactivity.
A case of acute respiratory failure after charcoal
aspiration with recurrent release of charcoal from an
intrapulmonary cavern has been reported by Francis et al.
[80].
Communication and teaching
Rego Lins Fumis and Deheinzelin reported on satisfaction
and prevalence of symptoms of anxiety and depression in
family members of 300 critically ill cancer patients [81].
Prevalence of anxiety and depression in family members
was 71 and 50.3%, respectively. Anxiety was indepen-
dently associated with prolonged mechanical ventilation,
relative’s gender and religion. Factors associated with
symptoms of depression were presence of metastasis and
relative’s gender.
Stricker et al. [82] assessed family satisfaction in the
relatives of 996 Swiss ICU patients. Overall, proxies were
satisﬁed with care and with information/decision-making.
Higher severity of illness was associated with higher
satisfaction, whereas a higher patient:nurse ratio and
written admission/discharge criteria were associated with
lower overall satisfaction. The need for improving emo-
tional support, coordination of care and communication
was highlighted.
In a multicenter before/after observational study,
Tremey et al. [83] assessed the compliance and impact
of a teaching program on guidelines for the management
of severe bleeding under oral anticoagulation therapy in
EDs. Forty-ﬁve patients with severe bleeding under oral
anticoagulation therapy were included in 2003 and 54
patients in 2005. The intervention consisted of a training
program on management of severe bleeding under oral
anticoagulation therapy performed by an expert physi-
cian. The primary end-point was the use of a
prothrombin complex concentrate-vitamin K combina-
tion between the two study periods. Nine patients (20%)
in 2003 and only 29 patients (54%) in 2005 received this
combination (P\0.01). Almost one-third of patients
had only withholding of oral anticoagulation therapy.
Adverse events and mortality rate did not differ between
the two phases.
423Chalumeau-Lemoine et al. [84] evaluated the impact
of limited training of ICU physicians without knowledge
of ultrasound in performing basic general ultrasonogra-
phy. After 8.5 h of training comprising a 2.5-h didactic
course that included essential views of normal and path-
ologic conditions and three hands-on sessions of 2 h each,
an ICU resident and a senior radiologist performed the
same examination in a blind manner. The questions
addressed concerned the presence of pleural effusion,
intra-abdominal effusion, acute cholecystitis, intrahepatic
biliary duct dilation, obstructive uropathy, chronic renal
disease and deep venous thrombosis. The answers to 129
questions were analyzed. Residents answered 84.4% of
the questions correctly. Most of the discrepancies con-
cerned small non-drainable pleural or abdominal
effusions. For questions with a potential therapeutic
impact, residents answered 95% of the questions cor-
rectly. Residents completed the examination in
37 ± 39 min compared with 296 ± 487 min for the
radiologists.
Intensive care medicine has developed rapidly and to a
considerable extent throughout the past 10–15 years.
Hence, it is most important to implement and adapt pro-
grams for training the physicians. Years ago, the
European Society of Intensive Care Medicine (ESICM)
was one of the ﬁrst contributors to the CoBaTrICE pro-
gram (Competency-Based Training in Intensive Care
MedicinE). Meanwhile, this program has been estab-
lished, and the CoBaTrICE Collaboration presented the
results from a recent survey in 28 European countries in a
report [85]. It was demonstrated that, although more than
half of the countries have modiﬁed their training pro-
grams since CoBaTrICE was initiated, national standards
for approving hospitals as training centers vary widely,
and there is considerable diversity in pedagogic structures
and processes. Nonetheless, the Collaboration will con-
tinue to harmonize and develop international standards for
quality assurance of training programs.
References
1. Spronk PE, Riekerk B, Hofhuis J,
Rommes JH (2009) Occurrence of
delirium is severely underestimated in
the ICU during daily care. Intensive
Care Med 35:1276–1280
2. Pandharipande PP, Morandi A, Adams
JR, Girard TD, Thompson JL, Shintani
AK, Ely EW (2009) Plasma tryptophan
and tyrosine levels are independent risk
factors for delirium in critically ill
patients. Intensive Care Med 35:1886–
1892
3. Myhren H, Toien K, Ekeberg O,
Karlsson S, Sandvik L, Stokland O
(2009) Patients’ memory and
psychological distress after ICU stay
compared with expectations of the
relatives. Intensive Care Med
35:2078–2086
4. Figueroa-Ramos MI, Arroyo-Novoa
CM, Lee KA, Padilla G, Puntillo KA
(2009) Sleep and delirium in ICU
patients: a review of mechanisms and
manifestations. Intensive Care Med
35:781–795
5. Davydow DS, Gifford JM, Desai SV,
Bienvenu OJ, Needham DM (2009)
Depression in general intensive care
unit survivors: a systematic review.
Intensive Care Med 35:796–809
6. Sena MJ, Rivers RM, Muizelaar JP,
Battistella FD, Utter GH (2009)
Transfusion practices for acute
traumatic brain injury: a survey of
physicians at US trauma centers.
Intensive Care Med 35:480–488
7. Lavinio A, Rasulo FA, De Peri E,
Czosnyka M, Latronico N (2009) The
relationship between the intracranial
pressure-volume index and cerebral
autoregulation. Intensive Care Med
35:546–549
8. Ichai C, Armando G, Orban JC,
Berthier F, Rami L, Samat-Long C,
Grimaud D, Leverve X (2009) Sodium
lactate versus mannitol in the treatment
of intracranial hypertensive episodes in
severe traumatic brain-injured patients.
Intensive Care Med 35:471–479
9. Sahuquillo J, Perez-Barcena J, Biestro
A, Zavala E, Merino MA, Vilalta A,
Poca MA, Garnacho A, Adalia R,
Homar J, LL-P JA (2009) Intravascular
cooling for rapid induction of moderate
hypothermia in severely head-injured
patients: results of a multicenter study
(IntraCool). Intensive Care Med
35:890–898
10. Hough CL, Steinberg KP, Taylor
Thompson B, Rubenfeld GD, Hudson
LD (2009) Intensive care unit-acquired
neuromyopathy and corticosteroids in
survivors of persistent ARDS. Intensive
Care Med 35:63–68
11. Herridge MS (2009) Building
consensus on ICU-acquired weakness.
Intensive Care Med 35:1–3
12. Kesler SM, Sprenkle MD, David WS,
Leatherman JW (2009) Severe
weakness complicating status
asthmaticus despite minimal duration of
neuromuscular paralysis. Intensive Care
Med 35:157–160
13. Pease S, Bouadma L, Kermarrec N,
Schortgen F, Regnier B, Wolff M
(2009) Early organ dysfunction course,
cooling time and outcome in classic
heatstroke. Intensive Care Med
35:1454–1458
14. Osman D, Monnet X, Castelain V,
Anguel N, Warszawski J, Teboul JL,
Richard C (2009) Incidence and
prognostic value of right ventricular
failure in acute respiratory distress
syndrome. Intensive Care Med
35:69–76
15. Mekontso Dessap A, Charron C,
Devaquet J, Aboab J, Jardin F,
Brochard L, Vieillard-Baron A (2009)
Impact of acute hypercapnia and
augmented positive end-expiratory
pressure on right ventricle function in
severe acute respiratory distress
syndrome. Intensive Care Med
35:1850–1858
16. Jochberger S, Velik-Salchner C, Mayr
VD, Luckner G, Wenzel V,
Falkensammer G, Ulmer H,
Morgenthaler N, Hasibeder W, Dunser
MW (2009) The vasopressin and
copeptin response in patients with
vasodilatory shock after cardiac
surgery: a prospective, controlled study.
Intensive Care Med 35:489–497
17. Monge Garcia MI, Gil Cano A, Diaz
Monrove JC (2009) Arterial pressure
changes during the Valsalva maneuver
to predict ﬂuid responsiveness in
spontaneously breathing patients.
Intensive Care Med 35:77–84
42418. Carr BG, Goyal M, Band RA, Gaieski
DF, Abella BS, Merchant RM, Branas
CC, Becker LB, Neumar RW (2009) A
national analysis of the relationship
between hospital factors and post-
cardiac arrest mortality. Intensive Care
Med 35:505–511
19. Marchick MR, Kline JA, Jones AE
(2009) The signiﬁcance of non-
sustained hypotension in emergency
department patients with sepsis.
Intensive Care Med 35:1261–1264
20. Dunser MW, Takala J, Ulmer H, Mayr
VD, Luckner G, Jochberger S, Daudel
F, Lepper P, Hasibeder WR, Jakob SM
(2009) Arterial blood pressure during
early sepsis and outcome. Intensive
Care Med 35:1225–1233
21. De Backer D, Heenen S, Piagnerelli M,
Koch M, Vincent JL (2005) Pulse
pressure variations to predict ﬂuid
responsiveness: inﬂuence of tidal
volume. Intensive Care Med 31:517–
523
22. Vallee F, Richard JC, Mari A, Gallas T,
Arsac E, Verlaan PS, Chousterman B,
Samii K, Genestal M, Fourcade O
(2009) Pulse pressure variations
adjusted by alveolar driving pressure to
assess ﬂuid responsiveness. Intensive
Care Med 35:1004–1010
23. Lefrant JY, De Backer D (2009) Can
we use pulse pressure variations to
predict ﬂuid responsiveness in patients
with ARDS? Intensive Care Med
35:966–968
24. Monnet X, Teboul JL (2008) Passive
leg raising. Intensive Care Med 34:659–
663
25. Jabot J, Teboul JL, Richard C, Monnet
X (2009) Passive leg raising for
predicting ﬂuid responsiveness:
importance of the postural change.
Intensive Care Med 35:85–90
26. Squara P, Cecconi M, Rhodes A, Singer
M, Chiche JD (2009) Tracking changes
in cardiac output: methodological
considerations for the validation of
monitoring devices. Intensive Care Med
35:1801–1808
27. Cecconi M, Dawson D, Grounds RM,
Rhodes A (2009) Lithium dilution
cardiac output measurement in the
critically ill patient: determination of
precision of the technique. Intensive
Care Med 35:498–504
28. D’Ancona G, Parrinello M, Santise G,
Biondo D, Pirone F, Sciacca S, Turrisi
M, Arcadipane A, Pilato M (2009)
Intraoperative validation of a new
system for invasive continuous cardiac
output measurement. Intensive Care
Med 35:943–947
29. Dellinger RP, Levy MM, Carlet JM,
Bion J, Parker MM, Jaeschke R,
Reinhart K, Angus DC, Brun-Buisson
C, Beale R, Calandra T, Dhainaut JF,
Gerlach H, Harvey M, Marini JJ,
Marshall J, Ranieri M, Ramsay G,
Sevransky J, Thompson BT, Townsend
S, Vender JS, Zimmerman JL, Vincent
JL (2008) Surviving sepsis campaign:
international guidelines for
management of severe sepsis and septic
shock: 2008. Intensive Care Med
34:17–60
30. Mesquida J, Masip J, Gili G, Artigas A,
Baigorri F (2009) Thenar oxygen
saturation measured by near infrared
spectroscopy as a noninvasive predictor
of low central venous oxygen saturation
in septic patients. Intensive Care Med
35:1106–1109
31. Trzeciak S, McCoy JV, Phillip
Dellinger R, Arnold RC, Rizzuto M,
Abate NL, Shapiro NI, Parrillo JE,
Hollenberg SM (2008) Early increases
in microcirculatory perfusion during
protocol-directed resuscitation are
associated with reduced multi-organ
failure at 24 h in patients with sepsis.
Intensive Care Med 34:2210–2217
32. den Uil CA, Caliskan K, Lagrand WK,
van der Ent M, Jewbali LS, van Kuijk
JP, Spronk PE, Simoons ML (2009)
Dose-dependent beneﬁt of nitroglycerin
on microcirculation of patients with
severe heart failure. Intensive Care Med
35:1893–1899
33. Dubin A, Pozo MO, Ferrara G, Murias
G, Martins E, Canullan C, Canales HS,
Kanoore Edul VS, Estenssoro E, Ince C
(2009) Systemic and microcirculatory
responses to progressive hemorrhage.
Intensive Care Med 35:556–564
34. Jhanji S, Lee C, Watson D, Hinds C,
Pearse RM (2009) Microvascular ﬂow
and tissue oxygenation after major
abdominal surgery: association with
post-operative complications. Intensive
Care Med 35:671–677
35. Vieillard-Baron A, Charron C, Chergui
K, Peyrouset O, Jardin F (2006)
Bedside echocardiographic evaluation
of hemodynamics in sepsis: is a
qualitative evaluation sufﬁcient?
Intensive Care Med 32:1547–1552
36. Arnold RC, Parrillo JE, Phillip
Dellinger R, Chansky ME, Shapiro NI,
Lundy DJ, Trzeciak S, Hollenberg SM
(2009) Point-of-care assessment of
microvascular blood ﬂow in critically ill
patients. Intensive Care Med 35:1761–
1766
37. Hartog C, Reinhart K (2009) CONTRA:
hydroxyethyl starch solutions are
unsafe in critically ill patients. Intensive
Care Med 35:1337–1342
38. Boldt J (2009) PRO:
hydroxyethylstarch can be safely used
in the intensive care patient–the renal
debate. Intensive Care Med 35:1331–
1336
39. Schabinski F, Oishi J, Tuche F, Luy A,
Sakr Y, Bredle D, Hartog C, Reinhart K
(2009) Effects of a predominantly
hydroxyethyl starch (HES)-based and a
predominantly non HES-based ﬂuid
therapy on renal function in surgical
ICU patients. Intensive Care Med
35:1539–1547
40. Boldt J, Suttner S, Brosch C, Lehmann
A, Rohm K, Mengistu A (2009) The
inﬂuence of a balanced volume
replacement concept on inﬂammation,
endothelial activation, and kidney
integrity in elderly cardiac surgery
patients. Intensive Care Med 35:462–
470
41. Morisaki H, Yajima S, Watanabe Y,
Suzuki T, Yamamoto M, Katori N,
Hashiguchi S, Takeda J (2009)
Hypercapnic acidosis minimizes
endotoxin-induced gut mucosal injury
in rabbits. Intensive Care Med
35:129–135
42. Gnaegi A, Feihl F, Boulat O, Waeber B,
Liaudet L (2009) Moderate hypercapnia
exerts beneﬁcial effects on splanchnic
energy metabolism during
endotoxemia. Intensive Care Med
35:1297–1304
43. Di Paola R, Menegazzi M, Mazzon E,
Genovese T, Crisafulli C, Dal Bosco M,
Zou Z, Suzuki H, Cuzzocrea S (2009)
Protective effects of glycyrrhizin in a
gut hypoxia (ischemia)-reoxygenation
(reperfusion) model. Intensive Care
Med 35:687–697
44. Zanotti-Cavazzoni SL, Guglielmi M,
Parrillo JE, Walker T, Dellinger RP,
Hollenberg SM (2009) Fluid
resuscitation inﬂuences cardiovascular
performance and mortality in a murine
model of sepsis. Intensive Care Med
35:748–754
45. Baumgart K, Simkova V, Wagner F,
Weber S, Georgieff M, Radermacher P,
Albuszies G, Barth E (2009) Effect of
SOD-1 over-expression on myocardial
function during resuscitated murine
septic shock. Intensive Care Med
35:344–349
46. Hagiwara S, Iwasaka H, Matsumoto S,
Noguchi T (2008) High dose
antithrombin III inhibits HMGB1 and
improves endotoxin-induced acute lung
injury in rats. Intensive Care Med
34:361–367
47. Hagiwara S, Iwasaka H, Hidaka S,
Hasegawa A, Koga H, Noguchi T
(2009) Antagonist of the type-1 ANG II
receptor prevents against LPS-induced
septic shock in rats. Intensive Care Med
35:1471–1478
42548. Hagiwara S, Iwasaka H, Hasegawa A,
Asai N, Noguchi T (2008) High-dose
intravenous immunoglobulin G
improves systemic inﬂammation in a rat
model of CLP-induced sepsis. Intensive
Care Med 34:1812–1819
49. Pugin J (2008) Dear SIRS, the concept
of ‘‘alarmins’’ makes a lot of sense!.
Intensive Care Med 34:218–221
50. Rehberg S, Ertmer C, Kohler G, Spiegel
HU, Morelli A, Lange M, Moll K,
Schlack K, Van Aken H, Su F, Vincent
JL, Westphal M (2009) Role of arginine
vasopressin and terlipressin as ﬁrst-line
vasopressor agents in fulminant ovine
septic shock. Intensive Care Med
35:1286–1296
51. Wolff S, Klatt S, Wolff JC, Wilhelm J,
Fink L, Kaps M, Rosengarten B (2009)
Endotoxin-induced gene expression
differences in the brain and effects of
iNOS inhibition and norepinephrine.
Intensive Care Med 35:730–739
52. Sykora R, Chvojka J, Krouzecky A,
Radej J, Karvunidis T, Varnerova V,
Novak I, Matejovic M (2009) High
versus standard-volume haemoﬁltration
in hyperdynamic porcine peritonitis:
effects beyond haemodynamics?
Intensive Care Med 35:371–380
53. Scheiermann P, Ahluwalia D, Hoegl S,
Dolfen A, Revermann M, Zwissler B,
Muhl H, Boost KA, Hofstetter C (2009)
Effects of intravenous and inhaled
levosimendan in severe rodent sepsis.
Intensive Care Med 35:1412–1419
54. Leendertse M, Willems RJ, Giebelen
IA, Florquin S, van den Pangaart PS,
Bonten MJ, van der Poll T (2009) Cecal
ligation and puncture induced sepsis
impairs host defense against
Enterococcus faecium peritonitis.
Intensive Care Med 35:924–932
55. Venet F, Chung CS, Kherouf H,
Geeraert A, Malcus C, Poitevin F, Bohe
J, Lepape A, Ayala A, Monneret G
(2009) Increased circulating regulatory
T cells (CD4(?)CD25 (?)CD127 (-))
contribute to lymphocyte anergy in
septic shock patients. Intensive Care
Med 35:678–686
56. Ferrari F, Liu ZH, Lu Q, Becquemin
MH, Louchahi K, Aymard G,
Marquette CH, Rouby JJ (2008)
Comparison of lung tissue
concentrations of nebulized ceftazidime
in ventilated piglets: ultrasonic versus
vibrating plate nebulizers. Intensive
Care Med 34:1718–1723
57. Ferrari F, Lu Q, Girardi C, Petitjean O,
Marquette CH, Wallet F, Rouby JJ
(2009) Nebulized ceftazidime in
experimental pneumonia caused by
partially resistant Pseudomonas
aeruginosa. Intensive Care Med
35:1792–1800
58. Caramez MP, Kacmarek RM, Helmy
M, Miyoshi E, Malhotra A, Amato MB,
Harris RS (2009) A comparison of
methods to identify open-lung PEEP.
Intensive Care Med 35:740–747
59. Dellaca RL, Andersson Olerud M,
Zannin E, Kostic P, Pompilio PP,
Hedenstierna G, Pedotti A, Frykholm P
(2009) Lung recruitment assessed by
total respiratory system input reactance.
Intensive Care Med 35:2164–2172
60. Steimback PW, Oliveira GP, Rzezinski
AF, Silva PL, Garcia CS, Rangel G,
Morales MM, Lapa ESJR, Capelozzi
VL, Pelosi P, Rocco PR (2009) Effects
of frequency and inspiratory plateau
pressure during recruitment
manoeuvres on lung and distal organs in
acute lung injury. Intensive Care Med
35:1120–1128
61. Pellicano A, Tingay DG, Mills JF,
Fasulakis S, Morley CJ, Dargaville PA
(2009) Comparison of four methods of
lung volume recruitment during high
frequency oscillatory ventilation.
Intensive Care Med 35:1990–1998
62. Martinez-Caro L, Lorente JA, Marin-
Corral J, Sanchez-Rodriguez C,
Sanchez-Ferrer A, Nin N, Ferruelo A,
de Paula M, Fernandez-Segoviano P,
Barreiro E, Esteban A (2009) Role of
free radicals in vascular dysfunction
induced by high tidal volume
ventilation. Intensive Care Med
35:1110–1119
63. Bueltmann M, Kong X, Mertens M, Yin
N, Yin J, Liu Z, Koster A, Kuppe H,
Kuebler WM (2009) Inhaled milrinone
attenuates experimental acute lung
injury. Intensive Care Med 35:171–178
64. Dyson A, Stidwill R, Taylor V, Singer
M (2009) The impact of inspired
oxygen concentration on tissue
oxygenation during progressive
haemorrhage. Intensive Care Med
35:1783–1791
65. Douzinas EE (2009) Progressive
hemorrhage: administer oxygen or early
resuscitation? Intensive Care Med
35:1664–1666
66. Hare GM, Liu E, Baker AJ, Mazer CD
(2009) Effect of oxygen afﬁnity on
systemic perfusion and brain tissue
oxygen tension after extreme
hemodilution with hemoglobin-starch
conjugates in rats. Intensive Care Med
35:1925–1933
67. Liu KX, Li YS, Huang WQ, Chen SQ,
Wang ZX, Liu JX, Xia Z (2009)
Immediate postconditioning during
reperfusion attenuates intestinal injury.
Intensive Care Med 35:933–942
68. Krouzecky A, Chvojka J, Sykora R,
Radej J, Karvunidis T, Novak I,
Ruzicka J, Petrankova Z, Benes J,
Bolek L, Matejovic M (2009) Regional
cooling of the extracorporeal blood
circuit: a novel anticoagulation
approach for renal replacement
therapy? Intensive Care Med 35:364–
370
69. Bagshaw SM, Davenport A (2009)
Cooling and reduced risk of clotting
within the extracorporeal continuous
renal replacement circuit. Intensive
Care Med 35:195–197
70. Mouly S, Meune C, Bergmann JF
(2009) Mini-series: I. Basic science.
Uncertainty and inaccuracy of
predicting CYP-mediated in vivo drug
interactions in the ICU from in vitro
models: focus on CYP3A4. Intensive
Care Med 35:417–429
71. Spriet I, Meersseman W, de Hoon J,
von Winckelmann S, Wilmer A,
Willems L (2009) Mini-series: II.
Clinical aspects. Clinically relevant
CYP450-mediated drug interactions in
the ICU. Intensive Care Med 35:603–
612
72. Schwake L, Wollenschlager I,
Stremmel W, Encke J (2009) Adverse
drug reactions and deliberate self-
poisoning as cause of admission to the
intensive care unit: a 1-year prospective
observational cohort study. Intensive
Care Med 35:266–274
73. Brown SG, Caruso N, Borland ML,
McCoubrie DL, Celenza A, Isbister GK
(2009) Clotting factor replacement and
recovery from snake venom-induced
consumptive coagulopathy. Intensive
Care Med 35:1532–1538
74. Struck MF, Hilbert P, Mockenhaupt M,
Reichelt B, Steen M (2009) Severe
cutaneous adverse reactions: emergency
approach to non-burn epidermolytic
syndromes. Intensive Care Med (in
press)
75. Migliari M, Bellani G, Rona R, Isgro S,
Vergnano B, Mauri T, Patroniti N,
Pesenti A, Foti G (2009) Short-term
evaluation of sedation with sevoﬂurane
administered by the anesthetic
conserving device in critically ill
patients. Intensive Care Med 35:1240–
1246
76. Kirwan CJ, Lee T, Holt DW, Grounds
RM, MacPhee IA, Philips BJ (2009)
Using midazolam to monitor changes in
hepatic drug metabolism in critically ill
patients. Intensive Care Med 35:1271–
1275
77. Ruokonen E, Parviainen I, Jakob SM,
Nunes S, Kaukonen M, Shepherd ST,
Sarapohja T, Bratty JR, Takala J (2009)
Dexmedetomidine versus propofol/
midazolam for long-term sedation
during mechanical ventilation.
Intensive Care Med 35:282–290
42678. Chanques G, Payen JF, Mercier G, de
Lattre S, Viel E, Jung B, Cisse M,
Lefrant JY, Jaber S (2010) Assessing
pain in non-intubated critically ill
patients unable to self report: an
adaptation of the Behavioral Pain Scale.
Intensive Care Med (in press)
79. Tardy-Poncet B, Wolf M, Lasne D,
Bauters A, Ffrench P, Elalamy I, Tardy
B (2009) Danaparoid cross-reactivity
with heparin-induced thrombocytopenia
antibodies: report of 12 cases. Intensive
Care Med 35:1449–1453
80. Francis RC, Schefold JC, Bercker S,
Temmesfeld-Wollbruck B, Weichert
W, Spies CD, Weber-Carstens S (2009)
Acute respiratory failure after aspiration
of activated charcoal with recurrent
deposition and release from an
intrapulmonary cavern. Intensive Care
Med 35:360–363
81. Rego Lins Fumis R, Deheinzelin D
(2009) Family members of critically ill
cancer patients: assessing the symptoms
of anxiety and depression. Intensive
Care Med 35:899–902
82. Stricker KH, Kimberger O, Schmidlin
K, Zwahlen M, Mohr U, Rothen HU
(2009) Family satisfaction in the
intensive care unit: what makes the
difference? Intensive Care Med
(in press)
83. Tremey B, Tazarourte K, Ract C,
Gabteni M, Lavagna L, Depret-Vassal
J, Segalin V, Saintonge S, Vigue B
(2009) Teaching improves adherence to
clinical guidelines in the treatment of
oral anticoagulation-related severe
bleeding in the emergency department.
Intensive Care Med 35:1444–1448
84. Chalumeau-Lemoine L, Baudel JL, Das
V, Arrive L, Noblinski B, Guidet B,
Offenstadt G, Maury E (2009) Results
of short-term training of naive
physicians in focused general
ultrasonography in an intensive-care
unit. Intensive Care Med 35:1767–1771
85. The CoBaTrICE Collaboration (2009)
The educational environment for
training in intensive care medicine:
structures, processes, outcomes and
challenges in the European region.
Intensive Care Med 35:1575–1583
427